Discussion The present initial results revealed no statistically significant difference between the EGCG and placebo groups in any of the anthropometric, glycemic, lipid or hormone peptide variables assessed
By binding two GHK molecules to each copper ion, the reactivity decreases while maintaining biological activity
Pilot clinical studies and case reports describe nausea in 65% of subjects at doses above 0,5 mg (resolution 2-4 h post-injection), flushing in 55%, transient increases in blood pressure and tachycardia in 40-60% of subjects, with peak acute effects occurring 90-120 minutes post-dose
Ingredients like alcohol, perfume, fragrance, witch hazel, essential oils must be omitted to keep the skin healthy and non-irritated